Resources
Practical articles, guides, and frameworks for drug development professionals. No fluff — just actionable insights from 20+ years of experience.
The majority of drug development failures are strategic, not scientific. Learn the five most common strategic pitfalls and how to structure your program to avoid them.
A target product profile is the single most important document in your drug development program. Here is how to build one that actually guides decisions.
Planning to file in both the US and Europe? Understanding the key differences between FDA and EMA requirements early saves months of rework later.
You cannot do everything at once. Here is how early-stage biotech companies should prioritize their development activities to maximize impact per dollar.
Building a drug delivery platform or personalized therapy system? Investors look for specific evidence of platform viability. Here is what to prepare.
One of the hardest decisions in drug development is knowing when to stop. A structured go/no-go framework removes emotion and saves resources.
Practical tools to support your drug development program.
A downloadable Target Product Profile template with guidance notes for each section.
Coming SoonPre-IND development checklist covering CMC, nonclinical, and clinical readiness.
Coming SoonSide-by-side comparison of FDA, EMA, and PMDA pathways for common drug types.
Coming SoonNew articles and insights published monthly. Follow along on LinkedIn or reach out to discuss any topic in depth.